Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Duval, Francis"'
Publikováno v:
ASTIN Bull. 54 (2024) 239-262
We present novel cross-sectional and longitudinal claim count models for vehicle insurance built upon the Combined Actuarial Neural Network (CANN) framework proposed by Mario W\"uthrich and Michael Merz. The CANN approach combines a classical actuari
Externí odkaz:
http://arxiv.org/abs/2308.01729
Usage-based insurance is becoming the new standard in vehicle insurance; it is therefore relevant to find efficient ways of using insureds' driving data. Applying anomaly detection to vehicles' trip summaries, we develop a method allowing to derive a
Externí odkaz:
http://arxiv.org/abs/2209.11763
It has been shown several times in the literature that telematics data collected in motor insurance help to better understand an insured's driving risk. Insurers that use this data reap several benefits, such as a better estimate of the pure premium,
Externí odkaz:
http://arxiv.org/abs/2105.14055
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Duval, Francis1 (AUTHOR) duval.francis.2@courrier.uqam.ca, Boucher, Jean‐Philippe1 (AUTHOR), Pigeon, Mathieu1 (AUTHOR)
Publikováno v:
Journal of Risk & Insurance. Jun2023, Vol. 90 Issue 2, p421-458. 38p. 1 Diagram, 12 Charts, 12 Graphs.
Publikováno v:
North American Actuarial Journal; 2022, Vol. 26 Issue 4, p570-590, 21p
Autor:
Duval, Francis, Pigeon, Mathieu
Publikováno v:
Risks, Vol 7, Iss 3, p 79 (2019)
In this paper, we propose models for non-life loss reserving combining traditional approaches such as Mack’s or generalized linear models and gradient boosting algorithm in an individual framework. These claim-level models use information about eac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::cc1049ba91f65750fc65c10fa066b3fc
https://www.mdpi.com/2227-9091/7/3/79
https://www.mdpi.com/2227-9091/7/3/79
Autor:
Glenn Duval Francis, Michael Bilous, Richard Bell, Peter Robbins, Margaret C. Cummings, Jane E. Armes, Gelareh Farshid, Glenda McCue, Martin Haswell, Wendy A. Raymond, Adrienne Morey, Stephen B. Fox
Publikováno v:
ResearcherID
In August 2006, the Australian government announced a decision to subsidize trastuzumab therapy for early breast cancer, to commence 6 weeks later. It was mandated that HER2 gene amplification, determined by in situ hybridization (ISH), be shown, and
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30c22808f7510f9fe57d7d7c630e4eec
https://doi.org/10.1097/pdm.0b013e3181e1cc9d
https://doi.org/10.1097/pdm.0b013e3181e1cc9d